Fibrates are 🔥 right now Many of us add fenofibrate to urso when our patients with PBC do not fully respond Here is more retrospective data to consider in Hepatology Communications: aasldpubs.onlinelibrary.wiley.com/doi/epdf/10.10… #livertwitter High rates of alk phos normalization

🥇 Honored and thrilled to receive the 2024 AASLD Foundation Emerging Liver Scholar Award 🥇 Excited for the opportunity to connect and share knowledge with #liver lovers 💪🏻 🎯This opportunity brings me one step closer to my dream of researching PSC-IBD This wouldn’t be

Congrats to Romelia Barba MD for being named as a 2024 AASLD Foundation Emerging Liver Scholar 🏆 No one more deserving! Reminiscing about the first day we met, her enthusiasm for hepatology was palpable and has only grown stronger. Proud is an understatement! 🌟 AASLD

Excited to congratulate another former research fellow on winning the Liver Scholar Award! This is what mentorship is all about - supporting the next generation of academic stars. Our research group is committed to fostering the growth of future leaders in the field. Vilas Patwardhan

Acculturation is associated with an increased risk of hepatic steatosis in the LatinX population. Encouraging a healthy diet and lifestyle is crucial for liver health. Learn more in our new article. #acculturation #latinxhealth #masld ⁦Daniela Goyes, MD⁩ journals.lww.com/cld/fulltext/2…

Exciting news! According to the latest SRTR report, BIDMC is now the #1 transplant center in the area for best outcomes and lowest waitlist mortality. We're honored to continue providing top-quality care to our transplant patients. #transplant #BIDMC #SRTR BIDMCTransplant

An honor to be selected for this year’s AASLD #LiverMeeting as ELS Alumni Leader ⭐️🙌🏻 Can’t wait to meet all the incoming ELS stars and learn about their journey and contributions to #Livertwitter Thank you AASLD Foundation ❤️!

After a long waiting time, I am excited to apply to the fellowship of my dreams: #Gastroenterology! Thank you Rutgers New Jersey Medical School Rutgers Internal Medicine Residency , and BIDMC_GI BIDMCTransplant for helping me become the person I am! #GIFellowship

New study from Global PBC highlights the importance of longitudinal FibroScan measurements in assessing liver prognosis! Regular monitoring can lead to better outcomes and individualized treatment plans. #LiverHealth #FibroScan cghjournal.org/article/S1542-…

Los #divertículos,la patología frecuente del #colon en occidente, relacionado con una #dieta baja en fibra y rica en carbohidratos refinados, #obesidad y sedentarismo “Adelántate y cuida tu colon” campaña de Alfasigma España, S.L. avalada por la #FEAD #adelantateycuidatucolon

Excited to share our new paper on the importance of validating prognostic scores for PBC (primary biliary cholangitis) prognosis! Proper validation is crucial to ensure accurate prediction of UDCA (ursodeoxycholic acid) response in a clinical setting. #PBC #prognosis

Ana Marenco Flores John Esli Medina Romelia Barba MD Vilas Patwardhan BIDMC Department of Medicine

Can we predict treatment response in #PBC patients using risk scores like GLOBE and UK-PBC? 💊📊 Our US prospective validation study shows both scores effectively predict UDCA response, helping identify patients at risk of incomplete response early on mdpi.com/2894922

Excited to share the amazing work being done by our autoimmune disease research team! Their dedication and innovative thinking are truly making a difference in the lives of those affected. #AutoimmuneAwareness

Exciting news to share from BIDMC! Our team successfully performed the first laparoscopic donor surgery, marking a major step forward for our Living Donor Transplant Program. We are so proud of our dedicated team for their hard work and commitment to improving the lives of our

Exciting news for PBC patients! The FDA has approved Livdelzi (seladelpar) – a significant advancement in therapy options. It's incredible to see the progress being made in the treatment of this rare disease. #PBC #Livdelzi #FDAapproval

🔍 HRS-AKI dx: Cirrhosis with ascites+📈creatinine ≥0.3 mg/dl within 48h or ≥50% from baseline+no improvement within 24h+No other cause. 💉 The consensus advises against systematic albumin administration for 48h for HRS-AKI diagnosis. #livertwitter journal-of-hepatology.eu/article/S0168-…

Thank you, Dr. Ramon Bataller, for spotlighting our work. Our study shows that #MetALD carries a higher risk of cancer mortality compared to MASLD. Interesting study led by Majd Aboona, MD Journal of Gastroenterology and Hepatology Karn Wijarnpreecha Juan Pablo (JP) Arab, MD  Mazen Noureddin, MD, MHSc Naim Alkhouri

How to combine FIB-4 and Elastography to screen for liver fibrosis ? Which algorithms are proposed by the main liver/GI societies ? I find this summarizing figure very useful. t.ly/V6cvF